- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04222504
Community-based Venues for Delivery of Healthcare Services: Proof of Concept Pilot
Community-based Venues for Delivery of Healthcare Services in Umlazi, South Africa: Proof of Concept Pilot Conducted in Hair Salons
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Durban, South Africa
- Adrenergy Research Innovations
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Female
- 18 years or older
- English or Zulu speaking
- Able and willing to consent
Exclusion Criteria:
- Symptoms of acute HIV viral syndrome
- Known pregnancy at baseline
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention Salons
Intervention: Behavioral: Provision of sexual health preventative services in the salon setting
|
Participants at intervention salons will be offered a choice of receiving daily PrEP and/or contraceptives (oral and injectables). Participants that elect to receive at least PrEP or contraceptives will also be offered STI testing. Follow-up visits will be planned for 3, 6, 9, and 12-months. Attendance at follow-up visits for monitoring and medication refill will be encouraged using text message reminders, WhatsApp support groups, and lottery-based incentives for free salon services.
Other Names:
|
|
No Intervention: Control Salon
No Intervention
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Uptake of Preventative Sexual Health Services
Time Frame: Months 4 to 16
|
We will measure uptake of the intervention as the proportion of eligible women who agree to salon-based contraception (first-time users and new users) and separately to salon-based PrEP.
|
Months 4 to 16
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Ingrid V. Bassett, MD, MPH, Massachusetts General Hospital
Publications and helpful links
General Publications
- Bassett IV, Yan J, Govere S, Shezi S, Ngcobo LM, Sagar S, Jarolimova J, Zionts D, Khumalo A, Zwane Z, Psaros C, Dube N, Parker RA. A pilot cluster randomized controlled trial assessing uptake of PrEP and contraception in hair salons in South Africa. BMC Public Health. 2025 Feb 8;25(1):524. doi: 10.1186/s12889-025-21718-3.
- Govere SM, Jarolimova J, Yan J, Shezi S, Ngcobo LM, Sagar S, Zionts D, Dube N, Parker RA, Psaros C, Bassett I. Uptake of HIV pre-exposure prophylaxis and contraception in South African hair salons: a study protocol for a pilot cluster randomised controlled trial. BMJ Open. 2024 Dec 20;14(12):e083621. doi: 10.1136/bmjopen-2023-083621.
- Jarolimova J, Yan J, Govere S, Shezi S, Ngcobo LM, Sagar S, Zionts D, Dube N, Parker RA, Bassett IV. Sexually Transmitted Infection Testing Integrated With HIV Prevention and Contraceptive Services in Hair Salons in Urban South Africa. J Acquir Immune Defic Syndr. 2025 Aug 1;99(4):359-367. doi: 10.1097/QAI.0000000000003677.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Urogenital Diseases
- Genital Diseases
- Pathologic Processes
- Disease Attributes
- Infections
- Communicable Diseases
- Pathological Conditions, Signs and Symptoms
- Behavior
- Reproductive Behavior
- Sexually Transmitted Diseases
- Contraception Behavior
- Heterocyclic Compounds, 1-Ring
- Heterocyclic Compounds
- Therapeutics
- Drug Administration Routes
- Drug Therapy
- Nucleic Acids, Nucleotides, and Nucleosides
- Deoxycytidine
- Cytidine
- Pyrimidine Nucleosides
- Pyrimidines
- Reproductive Techniques
- Nucleosides
- Deoxyribonucleosides
- Contraception
- Emtricitabine
- Injections
- Hormonal Contraception
Other Study ID Numbers
- 2019P003869
- K24AI141036 (U.S. NIH Grant/Contract)
- BFC449/19 (Other Identifier: UKZN Biomedical Research Ethics Committee)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on STI
-
Massachusetts General HospitalNational Institute of Mental Health (NIMH); Fenway Community Health; Tuberculosis...CompletedHIV/STI Risk | HIV/STI IncidenceUnited States, India
-
Yale UniversityCompletedHIV Prevention | STI PreventionUnited States
-
Fundació Institut Germans Trias i PujolHospital Vall d'Hebron; Department of Health, Generalitat de CatalunyaNot yet recruiting
-
Kirby InstituteCompleted
-
University of ConnecticutNational Institute of Mental Health (NIMH)Completed
-
Fondazione ICONARecruitingPrEP | HIV | STI | HIV -1 Infection | STI Prevention | PrEP Adherence MonitoringItaly
-
University of Cape TownLondon School of Hygiene and Tropical Medicine; UMC Utrecht; Institut Pasteur; Institut... and other collaboratorsCompleted
-
Chinese University of Hong KongCompleted
-
Columbia UniversityNational Institute of Allergy and Infectious Diseases (NIAID)CompletedSTI | Sexually Transmitted Disease (STD) | Sexually Transmitted Infection (STI)United States
-
University of WashingtonTasso Inc.RecruitingHIV Prevention | STI | Pre-exposure ProphylaxisUnited States
Clinical Trials on Provision of sexual health preventative services in the salon setting
-
Assistance Publique Hopitaux De MarseilleNot yet recruitingQuality of Life | Mental Health | Sexual Violence | Physical Health | Refugee Health | Access to Recommended HealthcareFrance
-
University of Colorado, DenverCancer League of ColoradoNot yet recruitingNewly Diagnosed Breast Cancer | Breast Cancer FemalesUnited States
-
Kathmandu University School of Medical SciencesNot yet recruitingQuality of Life | Self Care | Interdialytic Weight Gain | Patients on Hemodialysis | Nurse Led InterventionsNepal
-
Karadeniz Technical UniversityCompletedSurgery | Appendicitis | ERASTurkey (Türkiye)
-
University of Alabama at BirminghamNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and other collaboratorsRecruitingAutoimmune Diseases | Rheumatologic DiseaseUnited States
-
Bjorn H. EbdrupUniversity of Toronto; Herlev and Gentofte Hospital; Mental Health Centre GlostrupRecruitingSchizophrenia Spectrum and Other Psychotic Disorders | Bipolar Disorder | Severe Mental Disorder | Metabolic Complication | Side-Effect;MedicationDenmark
-
Oman Ministry of HealthCompletedSchizophenia Disorder | Forensic Psychiatric PatientsOman
-
CHU de Quebec-Universite LavalTerSera Therapeutics LLCSuspendedProstate Cancer | Radiotherapy Side Effect | Node; ProstateCanada
-
Mayo ClinicEnrolling by invitationCervical Carcinoma | Human Papillomavirus Infection | Human Papillomavirus-Related Cervical CarcinomaUnited States
-
Memorial Sloan Kettering Cancer CenterAckerman Institute for FamilyActive, not recruitingSupport of the Family as a Caregiving SystemUnited States